Hadeel Delman Najim, Mohammed Mahmood Mohammed, and Abbas Mahdi Rahmah. “Influence of Adding Empagliflozin to Conventional Anti-Diabetic Therapy on Quality of Life Scale for Type 2 Diabetic Patients”. Iraqi Journal of Pharmaceutical Sciences 33, no. 3 (September 15, 2024): 142–149. Accessed November 21, 2024. https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/2742.